David Rog

3.6k total citations · 1 hit paper
62 papers, 1.4k citations indexed

About

David Rog is a scholar working on Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, David Rog has authored 62 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pathology and Forensic Medicine, 15 papers in Public Health, Environmental and Occupational Health and 10 papers in Immunology. Recurrent topics in David Rog's work include Multiple Sclerosis Research Studies (39 papers), Pregnancy and Medication Impact (10 papers) and Polyomavirus and related diseases (8 papers). David Rog is often cited by papers focused on Multiple Sclerosis Research Studies (39 papers), Pregnancy and Medication Impact (10 papers) and Polyomavirus and related diseases (8 papers). David Rog collaborates with scholars based in United Kingdom, United States and Germany. David Rog's co-authors include Carolyn Young, Turo Nurmikko, Tim Friede, Owen Pearson, Richard Nicholas, Nick S. Jones, Gordon Mazibrada, Chris McGuigan, Raj Kapoor and Paul Molyneux and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

David Rog

59 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis

2005 504 citations David Rog, Turo Nurmikko et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Rog United Kingdom	16	572	561	274	209	195	62	1.4k
Iveta Nováková Czechia	7	304 0.5×	493 0.9×	257 0.9×	79 0.4×	29 0.1×	7	848
John D. Markman United States	22	434 0.8×	482 0.9×	346 1.3×	522 2.5×	46 0.2×	61	1.6k
Friedrich Ebinger Germany	24	192 0.3×	102 0.2×	214 0.8×	196 0.9×	28 0.1×	74	1.9k
Farhad F. Shadan United States	17	110 0.2×	161 0.3×	131 0.5×	318 1.5×	170 0.9×	29	1.2k
Khalid El‐Salem Jordan	17	307 0.5×	73 0.1×	471 1.7×	139 0.7×	53 0.3×	85	1.3k
Cynthia L. Renn United States	21	101 0.2×	260 0.5×	113 0.4×	477 2.3×	288 1.5×	57	1.3k
Michael Serpell United Kingdom	20	120 0.2×	379 0.7×	395 1.4×	651 3.1×	60 0.3×	28	1.3k
Pamela Stitzlein Davies United States	12	91 0.2×	409 0.7×	432 1.6×	1.0k 4.8×	185 0.9×	24	1.7k
Nastaran Majdinasab Iran	21	515 0.9×	53 0.1×	150 0.5×	143 0.7×	52 0.3×	84	1.0k
Stefan Seidel Austria	19	95 0.2×	87 0.2×	186 0.7×	215 1.0×	33 0.2×	79	1.5k

Countries citing papers authored by David Rog

Since Specialization

Citations

This map shows the geographic impact of David Rog's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Rog with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Rog more than expected).

Fields of papers citing papers by David Rog

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Rog. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Rog. The network helps show where David Rog may publish in the future.

Co-authorship network of co-authors of David Rog

This figure shows the co-authorship network connecting the top 25 collaborators of David Rog. A scholar is included among the top collaborators of David Rog based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Rog. David Rog is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Young, Carolyn, David Rog, Basil Sharrack, et al.. (2025). Clinical and socio-demographic characteristics of people with multiple sclerosis at the time of diagnosis: Influences on outcome trajectories. Journal of the Neurological Sciences. 470. 123409–123409. 2 indexed citations

Young, Carolyn, et al.. (2025). Employment status in people with multiple sclerosis: Profile, dynamic changes and determinants over time. Multiple Sclerosis and Related Disorders. 106. 106911–106911.

Henshall, David, Daoud Chaudhry, Setthasorn Zhi Yang Ooi, et al.. (2024). Delays in Multiple Sclerosis diagnosis (DIMES): protocol for a multicentre, observational study of multiple sclerosis diagnostic pathways in the United Kingdom and Republic of Ireland. BMC Neurology. 24(1). 105–105. 2 indexed citations

Rog, David, et al.. (2023). Ethnic disparities in the epidemiological and clinical characteristics of multiple sclerosis. Multiple Sclerosis and Related Disorders. 81. 105153–105153. 7 indexed citations

Rog, David, Wallace Brownlee, Francisco Javier Carod-Artal, et al.. (2023). Quantifying the administration and monitoring time burden of several disease-modifying therapies for relapsing multiple sclerosis in the United Kingdom: A time and motion study. Multiple Sclerosis and Related Disorders. 82. 105380–105380. 2 indexed citations

Wiles, Kate, Azza Ismail, Surabhi Nanda, et al.. (2023). Developing evidence-based guidelines for the safety of symptomatic drugs in multiple sclerosis during pregnancy and breastfeeding: A systematic review and Delphi consensus. Multiple Sclerosis Journal. 29(3). 395–406. 1 indexed citations

Young, Carolyn, David Rog, Radu Tănăsescu, et al.. (2023). Multiple Sclerosis vision questionnaire (MSVQ-7): Reliability, validity, precision and discrimination. Multiple Sclerosis and Related Disorders. 80. 105115–105115. 2 indexed citations

Knight, Jo, Rejith Dayanandan, Anthony G Marson, et al.. (2023). Outpatient neurology diagnostic coding: a proposed scheme for standardised implementation. Practical Neurology. 23(4). 317–322.

Dobson, Ruth, David Rog, Caroline Ovadia, et al.. (2022). Anti-CD20 therapies in pregnancy and breast feeding: a review and ABN guidelines. Practical Neurology. 23(1). 6–14. 24 indexed citations

10.

Dobson, Ruth, Matthew Craner, Aleisha Miller, et al.. (2021). OPTIMISE: MS study protocol: a pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosis. BMJ Open. 11(11). e050176–e050176. 2 indexed citations

11.

Garjani, Afagh, Rachael Hunter, Graham Law, et al.. (2021). Mental health of people with multiple sclerosis during the COVID-19 outbreak: A prospective cohort and cross-sectional case–control study of the UK MS Register. Multiple Sclerosis Journal. 28(7). 1060–1071. 20 indexed citations

12.

Garjani, Afagh, Rod Middleton, Rachael Hunter, et al.. (2021). COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies. Multiple Sclerosis and Related Disorders. 52. 102939–102939. 36 indexed citations

13.

Doshi, Anisha, David Paling, David Rog, et al.. (2021). A Systematic Review of Resting-State Functional MRI Connectivity Changes and Cognitive Impairment in Multiple Sclerosis. Brain Connectivity. 12(2). 112–133. 15 indexed citations

14.

Garjani, Alireza, Nikos Evangelou, Rajiv Nair, et al.. (2020). COVID-19 in people with MS: a large community-based study of the UK MS register. Multiple Sclerosis Journal. 26. 46–47. 1 indexed citations

15.

Roddam, Hazel, et al.. (2019). Inequalities in access to health and social care among adults with multiple sclerosis: A scoping review of the literature. Multiple Sclerosis and Related Disorders. 28. 290–304. 34 indexed citations

16.

Schlüter, Daniela K, Carolyn Young, R. J. Mills, et al.. (2018). Use of coping strategies in multiple sclerosis: Association with demographic and disease-related characteristics✰. Multiple Sclerosis and Related Disorders. 27. 214–222. 27 indexed citations

17.

Rog, David, et al.. (2017). Acute respiratory distress syndrome following alemtuzumab therapy for relapsing multiple sclerosis. Multiple Sclerosis and Related Disorders. 14. 1–3. 20 indexed citations

18.

Chhetri, Suresh Kumar, et al.. (2012). The unfolding tale of an unusual brain stem syndrome. Practical Neurology. 12(1). 55–59. 1 indexed citations

19.

Rog, David, Turo Nurmikko, Tim Friede, & Carolyn Young. (2007). Validation and Reliability of the Neuropathic Pain Scale (NPS) in Multiple Sclerosis. Clinical Journal of Pain. 23(6). 473–481. 37 indexed citations

20.

Rog, David & John Mottershead. (2006). The role of interferon beta in multiple sclerosis management. 7(3). 15–19. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact